Stemline Therapeutics Inc (NASDAQ:STML)

19.40
Delayed Data
As of 4:00pm ET
 -0.35 / -1.77%
Today’s Change
7.30
Today|||52-Week Range
20.20
+24.36%
Year-to-Date
No recent news for Stemline Therapeutics Inc.

Today’s Trading

Previous close19.75
Today’s open19.80
Day’s range19.20 - 19.90
Volume207,504
Average volume (3 months)310,051
Market cap$588.8M
Data as of 4:00pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)-36.74%
Earnings growth (this year)+5.24%
Earnings growth (next 5 years)--
Revenue growth (last year)-13.75%
P/E ratioNM
Price/Sales400.46
Price/Book10.46

Competitors

 Today’s
change
Today’s
% change
MDGLMadrigal Pharmaceuti...-1.81-1.47%
OVIDOvid Therapeutics In...-0.18-2.16%
ZYMEZymeworks Inc-0.10-0.56%
CMRXChimerix Inc-0.04-0.85%
Data as of 4:00pm ET, 05/23/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.66
Annual revenue (last year)$898.2K
Annual profit (last year)-$67.8M
Net profit margin-7,551.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Ivan Bergstein
Chief Operating Officer &
Secretary
Kenneth Hoberman
Corporate headquarters
New York, New York

Forecasts